Viewing Study NCT00675012


Ignite Creation Date: 2025-12-26 @ 11:10 AM
Ignite Modification Date: 2025-12-29 @ 7:22 AM
Study NCT ID: NCT00675012
Status: COMPLETED
Last Update Posted: 2014-05-30
First Post: 2008-05-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
Sponsor: AGC Biologics S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module